Multidrug resistance protein 4 (MRP4) expression in prostate cancer is associated with androgen signaling and decreases with tumor progression

FOXA1 Promotes Tumor Progression in Prostate Cancer and Represents a Novel Hallmark of Castration-Resistant Prostate Cancer

(2011) Josefine Gerhardt et al.   AMERICAN JOURNAL OF PATHOLOGY

Expression of SLCO1B3 is associated with intratumoral cholestasis and CTNNB1 mutations in hepatocellular carcinoma

(2011) Shigeki Sekine et al.   CANCER SCIENCE

Multidrug Resistance Protein 4 (MRP4/ABCC4) Regulates cAMP Cellular Levels and Controls Human Leukemia Cell Proliferation and Differentiation

(2011) Sabrina Copsel et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Periostin is up-regulated in high grade and high stage prostate cancer

(2010) Verena Tischler et al.   BMC CANCER

The Fox Genes in the Liver: From Organogenesis to Functional Integration

(2010) John Le lay et al.   PHYSIOLOGICAL REVIEWS

FOXA1 in breast cancer

(2009) Harikrishna Nakshatri et al.   EXPERT REVIEWS IN MOLECULAR MEDICINE

A role for the androgen-receptor in clinically localized and advanced prostate cancer

(2008) James L. Mohler   BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM

Hepatocyte-specific ablation of Foxa2 alters bile acid homeostasis and results in endoplasmic reticulum stress

(2008) Irina M Bochkis et al.   NATURE MEDICINE

Androgen regulation of multidrug resistance-associated protein 4 (MRP4/ABCC4) in prostate cancer

(2008) Lye Lin Ho et al.   PROSTATE

Multidrug resistance protein 4 (MRP4/ABCC4): a versatile efflux transporter for drugs and signalling molecules

(2008) F RUSSEL et al.   TRENDS IN PHARMACOLOGICAL SCIENCES

Up-regulation of MRP4 and down-regulation of influx transporters in human leukemic cells with acquired resistance to 6-mercaptopurine

(2007) Xing-Xiang Peng et al.   LEUKEMIA RESEARCH